Author | C. Kent Osborne, MD | OncLive

Author | C. Kent Osborne, MD

Articles

Dr. Osborne on Evaluating HER2 Positivity in Breast Cancer

October 07, 2019

Video

C. Kent Osborne, MD, discusses the important take home message for physicians treating patients with HER2-positive breast cancer. Osborne says the role of HER2-positivity is complicated.

Dr. Osborne on Pertuzumab in HER2+ Breast Cancer

April 25, 2017

Video

Kent Osborne, MD, director, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, discusses pertuzumab (Perjeta) in HER2-positive breast cancer.

Dr. Osborne Discusses Targeting the HER2 Pathway in Breast Cancer

April 18, 2017

Video

C. Kent Osborne, MD, director, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, discusses targeting the HER2 pathway in breast cancer.

Dr. Osborne on the Benefits of Dual-Targeted Therapy for HER2+ Breast Cancer

March 25, 2017

Video

C. Kent Osborne, MD, director, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, discusses the benefits of dual-targeted therapy for patients with HER2-positive breast cancer.

x